Prognostic value of some ovarian reserve tests in poor responders

Arch Gynecol Obstet. 2005 Jun;272(1):74-9. doi: 10.1007/s00404-004-0713-z. Epub 2005 Jan 20.

Abstract

Background: The objective of this study was to determine the prognostic value of the basal estradiol (E2) and inhibin-B levels, the antral follicle count (AFC), and the clomiphene citrate challenge test (CCCT) of ovarian response in controlled ovarian hyperstimulation (COH), in an outcome with normal follicle-stimulating hormone (FSH) concentration in the early follicular phase of the menstrual cycle.

Methods: Fifty-two patients undergoing IVF treatment were included in the study. Blood samples were collected for assessment of basal E2, FSH, and inhibin-B levels. Transvaginal ultrasound of an unstimulated cycle was performed to determine the mean antral follicle count (AFC). Serum FSH concentration was measured again on day 10 for CCCT performance.

Results: The mean values of women's age, and basal and day 10 FSH levels were significantly higher in cancelled cycles than in the control group, whereas basal inhibin-B and AFC were significantly higher in the latter. The mean basal E2 concentration was similar in both groups. The results from the logistic regression analysis show that CCCT (cut-off point FSH > 12.5 mIU/ml; AUCROC = 0.90) was a better single predictor of poor ovarian response than AFC (AUCROC = 0.85) and inhibin-B (AUCROC = 0.79) with a correct prediction for CCCT (86.5%), antral follicle count (84.6%), and for inhibin-B (82.7%).

Conclusions: In women with normal basal FSH level, the determination of E2 has no prognostic value for the outcome of poor responders. However, CCCT, AFC, and inhibin-B tests, when applied separately, produce good prognostic values. CCCT is the best single predictor of poor ovarian response, followed by antral follicle count and basal inhibin-B values. In spite of that, CCCT does not add significantly to the simpler AFC ultrasound test in the prediction of poor ovarian response.

MeSH terms

  • Adult
  • Biomarkers / blood
  • Body Mass Index
  • Case-Control Studies
  • Clomiphene
  • Estradiol / blood*
  • Estrogen Antagonists
  • Female
  • Follicle Stimulating Hormone / blood*
  • Humans
  • Inhibins / blood*
  • Logistic Models
  • Ovarian Follicle / diagnostic imaging
  • Ovarian Follicle / drug effects
  • Ovarian Function Tests / methods*
  • Ovarian Function Tests / standards
  • Ovary / diagnostic imaging
  • Ovary / drug effects
  • Ovary / physiology*
  • Prognosis
  • Prospective Studies
  • ROC Curve
  • Treatment Outcome
  • Ultrasonography

Substances

  • Biomarkers
  • Estrogen Antagonists
  • Clomiphene
  • Estradiol
  • Inhibins
  • Follicle Stimulating Hormone